Veraxa Biotech Holding AG (VRXA) Long-Term Deferred Tax (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted quarterly Long-Term Deferred Tax of $2.1 million for Q4 2025, up 28.57% year-over-year from $1.6 million in Q4 2024, and up 28.57% quarter-over-quarter from $1.6 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Long-Term Deferred Tax for 2 consecutive years, with $2.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Long-Term Deferred Tax rose 28.57% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (up 28.57% YoY), while the FY2025 annual figure was $2.1 million, up 28.57% from the prior year.
- Long-Term Deferred Tax climbed to $2.1 million in Q4 2025 per VRXA's latest filing, from $1.6 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $2.1 million in Q4 2025 and bottomed at $1.6 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | 1.60 Mn |